Annual SG&A
$12.87 B
-$2.39 B-15.65%
31 December 2023
Summary:
AbbVie annual selling, general & administrative expenses is currently $12.87 billion, with the most recent change of -$2.39 billion (-15.65%) on 31 December 2023. During the last 3 years, it has risen by +$1.57 billion (+13.92%). ABBV annual SG&A is now -15.65% below its all-time high of $15.26 billion, reached on 31 December 2022.ABBV Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$4.21 B
+$828.00 M+24.52%
30 September 2024
Summary:
AbbVie quarterly selling, general & administrative expenses is currently $4.21 billion, with the most recent change of +$828.00 million (+24.52%) on 30 September 2024. Over the past year, it has increased by +$833.00 million (+24.70%). ABBV quarterly SG&A is now -22.30% below its all-time high of $5.41 billion, reached on 30 June 2022.ABBV Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$12.12 B
-$5.90 B-94.82%
30 September 2024
Summary:
AbbVie TTM selling, general & administrative expenses is currently -$12.12 billion, with the most recent change of -$5.90 billion (-94.82%) on 30 September 2024. Over the past year, it has dropped by -$25.21 billion (-192.52%). ABBV TTM SG&A is now -152.63% below its all-time high of $15.26 billion, reached on 31 December 2022.ABBV TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ABBV Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -15.7% | +24.7% | -192.5% |
| 3 y3 years | +13.9% | +36.4% | -198.3% |
| 5 y5 years | +74.0% | +153.8% | -275.1% |
ABBV Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -15.7% | +13.9% | -22.3% | +38.4% | -166.0% | at low |
| 5 y | 5 years | -15.7% | +85.4% | -22.3% | +153.8% | -166.0% | at low |
| alltime | all time | -15.7% | +284.4% | -22.3% | +303.9% | -152.6% | at low |
AbbVie Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $4.21 B(+24.5%) | $14.09 B(+6.3%) |
| June 2024 | - | $3.38 B(+1.9%) | $13.26 B(+0.8%) |
| Mar 2024 | - | $3.31 B(+3.8%) | $13.15 B(+2.1%) |
| Dec 2023 | $12.87 B(-15.6%) | $3.19 B(-5.3%) | $12.87 B(-1.7%) |
| Sept 2023 | - | $3.37 B(+3.2%) | $13.10 B(+0.5%) |
| June 2023 | - | $3.27 B(+7.5%) | $13.03 B(-14.1%) |
| Mar 2023 | - | $3.04 B(-11.1%) | $15.17 B(-0.6%) |
| Dec 2022 | $15.26 B(+23.6%) | $3.42 B(+3.4%) | $15.26 B(+1.0%) |
| Sept 2022 | - | $3.30 B(-39.0%) | $15.10 B(+1.5%) |
| June 2022 | - | $5.41 B(+73.1%) | $14.88 B(+17.8%) |
| Mar 2022 | - | $3.13 B(-4.1%) | $12.63 B(+2.3%) |
| Dec 2021 | $12.35 B(+9.3%) | $3.26 B(+5.7%) | $12.35 B(+0.2%) |
| Sept 2021 | - | $3.08 B(-2.6%) | $12.32 B(+2.0%) |
| June 2021 | - | $3.16 B(+11.3%) | $12.08 B(-2.9%) |
| Mar 2021 | - | $2.84 B(-12.0%) | $12.45 B(+10.2%) |
| Dec 2020 | $11.30 B(+62.8%) | $3.23 B(+13.5%) | $11.30 B(+12.8%) |
| Sept 2020 | - | $2.85 B(-19.3%) | $10.02 B(+13.5%) |
| June 2020 | - | $3.53 B(+108.1%) | $8.83 B(+26.9%) |
| Mar 2020 | - | $1.70 B(-13.1%) | $6.96 B(+0.2%) |
| Dec 2019 | $6.94 B(-6.2%) | $1.95 B(+17.7%) | $6.94 B(+0.3%) |
| Sept 2019 | - | $1.66 B(+0.2%) | $6.92 B(-3.6%) |
| June 2019 | - | $1.65 B(-1.5%) | $7.18 B(-1.5%) |
| Mar 2019 | - | $1.68 B(-12.9%) | $7.29 B(-1.5%) |
| Dec 2018 | $7.40 B(+17.5%) | $1.93 B(+0.5%) | $7.40 B(-0.4%) |
| Sept 2018 | - | $1.92 B(+9.0%) | $7.43 B(+6.6%) |
| June 2018 | - | $1.76 B(-1.7%) | $6.96 B(+3.7%) |
| Mar 2018 | - | $1.79 B(-8.4%) | $6.71 B(+6.6%) |
| Dec 2017 | $6.29 B | $1.96 B(+34.2%) | $6.29 B(+4.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2017 | - | $1.46 B(-3.4%) | $6.02 B(+1.3%) |
| June 2017 | - | $1.51 B(+9.9%) | $5.94 B(+0.7%) |
| Mar 2017 | - | $1.37 B(-18.2%) | $5.90 B(+0.3%) |
| Dec 2016 | $5.88 B(-7.9%) | $1.68 B(+21.6%) | $5.88 B(-1.0%) |
| Sept 2016 | - | $1.38 B(-5.8%) | $5.94 B(-1.5%) |
| June 2016 | - | $1.47 B(+8.2%) | $6.03 B(-3.8%) |
| Mar 2016 | - | $1.35 B(-22.0%) | $6.27 B(-1.8%) |
| Dec 2015 | $6.39 B(-17.3%) | $1.74 B(+17.8%) | $6.39 B(-20.1%) |
| Sept 2015 | - | $1.47 B(-13.4%) | $7.99 B(-1.5%) |
| June 2015 | - | $1.70 B(+15.6%) | $8.11 B(+3.2%) |
| Mar 2015 | - | $1.47 B(-55.9%) | $7.86 B(+1.7%) |
| Dec 2014 | $7.72 B(+44.3%) | $3.34 B(+109.5%) | $7.72 B(+32.5%) |
| Sept 2014 | - | $1.59 B(+10.2%) | $5.83 B(+6.1%) |
| June 2014 | - | $1.45 B(+8.1%) | $5.50 B(+0.8%) |
| Mar 2014 | - | $1.34 B(-7.5%) | $5.46 B(+1.9%) |
| Dec 2013 | $5.35 B(+7.3%) | $1.45 B(+14.8%) | $5.35 B(+0.7%) |
| Sept 2013 | - | $1.26 B(-10.3%) | $5.32 B(+3.4%) |
| June 2013 | - | $1.41 B(+13.7%) | $5.14 B(+3.2%) |
| Mar 2013 | - | $1.24 B(-12.3%) | $4.98 B(-0.2%) |
| Dec 2012 | $4.99 B(-15.4%) | $1.41 B(+30.0%) | $4.99 B(+5.9%) |
| Sept 2012 | - | $1.08 B(-12.9%) | $4.71 B(-23.6%) |
| June 2012 | - | $1.25 B(-0.1%) | $6.17 B(+3.4%) |
| Mar 2012 | - | $1.25 B(+9.9%) | $5.96 B(+1.2%) |
| Dec 2011 | $5.89 B(+54.3%) | $1.13 B(-55.4%) | $5.89 B(+23.8%) |
| Sept 2011 | - | $2.54 B(+144.1%) | $4.76 B(+114.5%) |
| June 2011 | - | $1.04 B(-11.6%) | $2.22 B(+88.4%) |
| Mar 2011 | - | $1.18 B | $1.18 B |
| Dec 2010 | $3.82 B(+14.1%) | - | - |
| Dec 2009 | $3.35 B | - | - |
FAQ
- What is AbbVie annual selling, general & administrative expenses?
- What is the all time high annual SG&A for AbbVie?
- What is AbbVie annual SG&A year-on-year change?
- What is AbbVie quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for AbbVie?
- What is AbbVie quarterly SG&A year-on-year change?
- What is AbbVie TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for AbbVie?
- What is AbbVie TTM SG&A year-on-year change?
What is AbbVie annual selling, general & administrative expenses?
The current annual SG&A of ABBV is $12.87 B
What is the all time high annual SG&A for AbbVie?
AbbVie all-time high annual selling, general & administrative expenses is $15.26 B
What is AbbVie annual SG&A year-on-year change?
Over the past year, ABBV annual selling, general & administrative expenses has changed by -$2.39 B (-15.65%)
What is AbbVie quarterly selling, general & administrative expenses?
The current quarterly SG&A of ABBV is $4.21 B
What is the all time high quarterly SG&A for AbbVie?
AbbVie all-time high quarterly selling, general & administrative expenses is $5.41 B
What is AbbVie quarterly SG&A year-on-year change?
Over the past year, ABBV quarterly selling, general & administrative expenses has changed by +$833.00 M (+24.70%)
What is AbbVie TTM selling, general & administrative expenses?
The current TTM SG&A of ABBV is -$12.12 B
What is the all time high TTM SG&A for AbbVie?
AbbVie all-time high TTM selling, general & administrative expenses is $15.26 B
What is AbbVie TTM SG&A year-on-year change?
Over the past year, ABBV TTM selling, general & administrative expenses has changed by -$25.21 B (-192.52%)